BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18525341)

  • 1. Regional hyperthermia in high-risk soft tissue sarcomas.
    Issels RD
    Curr Opin Oncol; 2008 Jul; 20(4):438-43. PubMed ID: 18525341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
    Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry.
    Gellermann J; Hildebrandt B; Issels R; Ganter H; Wlodarczyk W; Budach V; Felix R; Tunn PU; Reichardt P; Wust P
    Cancer; 2006 Sep; 107(6):1373-82. PubMed ID: 16902986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy.
    Issels RD
    Int J Hyperthermia; 2006 May; 22(3):235-9. PubMed ID: 16754344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.
    Pennacchioli E; Fiore M; Gronchi A
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):199-210. PubMed ID: 19192958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-imaging changes of musculoskeletal soft-tissue sarcomas associated with neoadjuvant chemotherapy and hyperthermia.
    Baur A; Stäbler A; Wendtner CM; Arbogast S; Rahman SA; Santl M; Issels R; Reiser M
    Int J Hyperthermia; 2003; 19(4):391-401. PubMed ID: 12850925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions.
    Issels R; Lindner LH
    Curr Opin Oncol; 2016 Sep; 28(5):447-52. PubMed ID: 27455134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based recommendations for local therapy for soft tissue sarcomas.
    Pisters PW; O'Sullivan B; Maki RG
    J Clin Oncol; 2007 Mar; 25(8):1003-8. PubMed ID: 17350950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
    Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.
    Taeger G; Grabellus F; Podleska LE; Müller S; Ruchholtz S
    Int J Hyperthermia; 2008 May; 24(3):193-203. PubMed ID: 18392998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in adult soft tissue sarcoma.
    Jain A; Sajeevan KV; Babu KG; Lakshmaiah KC
    Indian J Cancer; 2009; 46(4):274-87. PubMed ID: 19749457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia--its actual role in radiation oncology. Part III: Clinical rationale and results in deep seated tumors.
    Feldmann HJ; Seegenschmiedt MH; Molls M
    Strahlenther Onkol; 1995 May; 171(5):251-64. PubMed ID: 7770780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas.
    Ferrari A
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):929-38. PubMed ID: 18533802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas.
    Ferrari A; Casanova M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):307-18. PubMed ID: 15877527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia adds to chemotherapy.
    Issels RD
    Eur J Cancer; 2008 Nov; 44(17):2546-54. PubMed ID: 18789678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM; Patel S
    Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives.
    Seifert G; Budach V; Keilholz U; Wust P; Eggert A; Ghadjar P
    Radiat Oncol; 2016 Apr; 11():65. PubMed ID: 27138749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven.
    Blay JY; Le Cesne A
    Oncologist; 2009 Oct; 14(10):1013-20. PubMed ID: 19808771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.
    Angele MK; Albertsmeier M; Prix NJ; Hohenberger P; Abdel-Rahman S; Dieterle N; Schmidt M; Mansmann U; Bruns CJ; Issels RD; Jauch KW; Lindner LH
    Ann Surg; 2014 Nov; 260(5):749-54; discussion 754-6. PubMed ID: 25379845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.